Of relevance, given the worse prognosis of ABC versus GCB DLBCL patients, no differential (i.e., lower) expression of CYLD was observed in ABC versus GCB DLBCL (Fig. 1A). This evidence concerns the gene CYLD and diffuse large B-cell lymphoma.